In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Acelity sells $1.75bn of its senior secured notes

Executive Summary

Wound care and regenerative medicine specialist Acelity LP Inc. and its Kinetic Concepts Inc./KCI USA Inc. subsidiaries sold $1.75bn in principal amount of 9.625% second lien senior secured notes due 2021. Proceeds and additional assets will be used to redeem $1.75bn in principal amount of outstanding 10.5% second lien senior secured notes due 2018.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Rehabilitation Equipment and Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Private Placement

Related Companies